Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Christopher W. Cain files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Fairmount Funds Management LLC - $370.02M in COGT purchases and sales in the last 12 months
- John Edward Robinson - $3.49M in COGT purchases and sales in the last 12 months
- Jessica Sachs - $3.20M in COGT purchases and sales in the last 12 months
- John L. Green - $2.98M in COGT purchases and sales in the last 12 months
- Evan Kearns - $2.52M in COGT purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Christopher W. Cain?
Christopher W. Cain is a corporate insider of Viridian Therapeutics, Inc.\DE (VRDN). InsiderAlpha holds 5 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Christopher W. Cain last file a Form 4?
The most recent primary Form 4 on record is dated 2 July 2026, one of 5 filings going back to 2025.
